David Chang
- Oncology top 2%
- Molecular Biology top 10%
- Hepatology top 1%
- Surgery top 10%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Huamin WangCathy EngLee M. EllisDaria ZorziDario RiberoEddie K. AbdallaSteven A. CurleyLaurence M. Epstein
- Topics
- Colorectal Cancer Treatments and Studies (13 papers)Pancreatic and Hepatic Oncology Research (10 papers)Cardiac pacing and defibrillation studies (9 papers)
- Cited by
- HepatologyOncologyCancer Research
- Partner nations
- United StatesChinaAustralia
In The Last Decade
David Chang
63 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 115
- Oncology 1.4k
- Molecular Biology 1000
- Hepatology 608
- Surgery 465
- Pulmonary and Respiratory Medicine 415
Countries citing papers authored by David Chang
This map shows the geographic impact of David Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chang more than expected).
Fields of papers citing papers by David Chang
This network shows the impact of papers produced by David Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chang. The network helps show where David Chang may publish in the future.
Co-authorship network of co-authors of David Chang
This figure shows the co-authorship network connecting the top 25 collaborators of David Chang. A scholar is included among the top collaborators of David Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chang. David Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 218 | |
| 4 | 229 | |
| 5 | 0 | |
| 6 | 16 | |
| 7 | 45 | |
| 8 | 7 | |
| 9 | 6 | |
| 10 | 0 | |
| 11 | 64 | |
| 12 | 98 | |
| 13 | 53 | |
| 14 | 75 | |
| 15 | 85 | |
| 16 | 63 | |
| 17 | 246 | |
| 18 | 278 | |
| 19 | 64 | |
| 20 | Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX. | 4 |
About David Chang
David Chang is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Medical Laboratory Technology, having authored 68 papers that have together received 2.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cardiac pacing and defibrillation studies (9 papers). The work is most often cited by research in Hepatology (608 citations), Oncology (1.4k citations) and Cancer Research (385 citations). David Chang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Huamin Wang, Cathy Eng, Lee M. Ellis, Daria Zorzi, Dario Ribero, Eddie K. Abdalla, Steven A. Curley, Laurence M. Epstein, Robert A. Wolff and Lorenzo Cohen. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.